Manejo endoscópico de la enfermedad por reflujo gastroesofágico (ERGE)

Arecio Peñaloza Ramírez; Mario Hugo Barrera Latorre

doi:10.31260/RepertMedCir.01217372.1303

Endoscopic management of gastroesophageal reflux disease (GERD)

Manejo endoscópico de la enfermedad por reflujo gastroesofágico (ERGE)

Published 2023-03-09

Open | Download

PDF (Spanish) FLIP HTML (Spanish) EPUB (Spanish) text/xml XML (Spanish) audio/mpeg AUDIO (mp3) (Spanish)

Issue

Vol. 32 No. 1 (2023)

Section

Reflection Articles

How to Cite

Peñaloza Ramírez, A., & Barrera Latorre, M. H. (2023). Endoscopic management of gastroesophageal reflux disease (GERD). Journal of Medicine and Surgery Repertoire, 32(1), 92-96. https://doi.org/10.31260/RepertMedCir.01217372.1303

DOI

https://doi.org/10.31260/RepertMedCir.01217372.1303

Dimensions

PlumX

Citations

Citations in Crossref

Citations in Scopus

Citations in Europe PMC

license

Arecio Peñaloza Ramírez

Fundación Universitaria de Ciencias de la Salud

https://orcid.org/0000-0001-9052-530X

Mario Hugo Barrera Latorre

Fundación Universitaria de Ciencias de la Salud

https://orcid.org/0000-0001-6916-1943

Show authors biography

Arecio Peñaloza Ramírez,

Investigador asociado, Colciencias, Jefe Programa Especialización en Gastroenterología y Endoscopia Digestiva, Fundación Universitaria de Ciencias de la Salud, Sociedad de Cirugía de Bogotá. Jefe Servicio de Gastroenterología y Endoscopia Digestiva, Hospital de San José. Bogotá, Colombia.

Mario Hugo Barrera Latorre,

Especialista en Cirugía General, Residente de Gastroenterología y Endoscopia Digestiva, Fundación Universitaria de Ciencias de la Salud, Sociedad de Cirugía de Bogotá, Hospital de San José, Colombia.

##plugins.themes.bootstrap3.displayStats.noStats##

Gastroesophageal Reflux disease

endoscopic treatment

mucosectomy

esophagus pH monitoring

Gastroesophageal reflux disease (GERD) occurs when gastric chyme refluxes back into the esophagus and changes from physiologic to symptomatic and pathologic. It is common worldwide and is difficult to diagnose due to the diversity of symptoms and presentations, making its therapeutic approach complex. Although there are multiple treatment options, proton pump inhibitors (PPIs) have been the mainstay of pharmacological management of GERD. Surgical treatment is described but is used in selected patients. Endoscopic therapy emerges as another option with similar indications as surgery, featuring the advantages of endoscopic procedures. Several endoluminal techniques have been described showing poor results, thus their generalized use has not been achieved.

Article visits 1064 | PDF visits 1047

Downloads

Download data is not yet available.

Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clinic Gastroenterol Heepatol. 2020;18(4):767-76. https://doi.org/10.1016/j.cgh.2019.07.015 DOI: https://doi.org/10.1016/j.cgh.2019.07.015
Páramo Hernández DB, Albis R, Galiano MT, Mendoza de Molano B, Rincón R, Pineda Ovalle LF, et al. Prevalencia de síntomas del reflujo gastroesofágico y factores asociados: una encuesta poblacional en las principales ciudades de Colombia. Rev. Colomb Gastroenterol. 2016;31(4):337-346. http://doi.org/10.22516/25007440.108 DOI: https://doi.org/10.22516/25007440.108
Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56. http://doi.org/10.14309/ajg.0000000000001538 DOI: https://doi.org/10.14309/ajg.0000000000001538
Richter JE, Rubenstein JH. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154(2):267-276. http://doi.org/10.1053/j.gastro.2017.07.045 DOI: https://doi.org/10.1053/j.gastro.2017.07.045
Hani AC, Galindo A, Leguizamo A, Maldonado C, Páramo H D, Costa V, et al. Guía de práctica clínica para la enfermedad por reflujo gastroesofágico. Rev. Colomb Gastroenterol. 2015;30(Supl.1):1-8.
Mayor MA, Fernando HC. Endoluminal Approaches to Gastroesophageal Reflux Disease. Thorac Surg Clin. 2018;28(4):527-532. http://doi.org/10.1016/j.thorsurg.2018.07.008 DOI: https://doi.org/10.1016/j.thorsurg.2018.07.008
Lo WK, Mashimo H. Critical Assessment of Endoscopic Techniques for Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2015;49(9):720-724. http://doi.org/10.1097/mcg.0000000000000389 DOI: https://doi.org/10.1097/MCG.0000000000000389
Wong HJ, Su B, Attaar M, Kuchta K, Stearns S, Linn JG, et al. Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication. Surg Endosc. 2021;35:7174-82. http://doi.org/10.1007/s00464-020-08144-9 DOI: https://doi.org/10.1007/s00464-020-08144-9
Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27(4):346-351.
Nicolau AE, Lobonţiu A, Constantinoiu S. New Minimally Invasive Endoscopic and Surgical Therapies for Gastroesophageal Reflux Disease (GERD). Chirurgia (Bucur). 2018;113(1):70-82. http://doi.org/10.21614/chirurgia.113.1.70 DOI: https://doi.org/10.21614/chirurgia.113.1.70
Kushner BS, Awad MM, Mikami DJ, Chand BB, Wai CJ, Murayama KM. Endoscopic treatments for GERD. Ann N Y Acad Sci. 2020;1482(1):121-129. http://doi.org/10.1111/nyas.14511 DOI: https://doi.org/10.1111/nyas.14511
Richter JE, Kumar A, Lipka S, Miladinovic B, Velanovich V. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis. Gastroenterology. 2018;154(5):1298-1308.e7. http://doi.org/10.1053/j.gastro.2017.12.021 DOI: https://doi.org/10.1053/j.gastro.2017.12.021
Rouphael C, Padival R, Sanaka MR, Thota PN. Endoscopic Treatments of GERD. Curr Treat Options Gastroenterol. 2018;16(1):58-71. http://doi.org/10.1007/s11938-018-0170-6 DOI: https://doi.org/10.1007/s11938-018-0170-6
Satodate H, Inoue H, Yoshida T, Usui S, Iwashita M, Fukami N, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report. Gastrointest Endosc. 2003;58(2):288-292. http://doi.org/10.1067/mge.2003.361 DOI: https://doi.org/10.1067/mge.2003.361
Satodate H, Inoue H, Fukami N, Shiokawa A, Kudo SE. Squamous reepithelialization after circumferential endoscopic mucosal resection of superficial carcinoma arising in Barrett's esophagus. Endoscopy. 2004;36(10):909-912.http://doi.org/10.1055/s-2004-825830 DOI: https://doi.org/10.1055/s-2004-825830
Monino L, Gonzalez JM, Vitton V, Barthet M. Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control. Endosc Int Open. 2020;8(2):E147-e54.http://doi.org/10.1055/a-1038-4012 DOI: https://doi.org/10.1055/a-1038-4012
Debourdeau A, Vitton V, Monino L, Barthet M, Gonzalez JM. Antireflux Mucosectomy Band (ARM-b) in Treatment of Refractory Gastroesophageal Reflux Disease After Bariatric Surgery. Obes Surg. 2020;30(11):4654-4658.http://doi.org/10.1007/s11695-020-04753-4 DOI: https://doi.org/10.1007/s11695-020-04753-4
Sumi K, Inoue H, Kobayashi Y, Iwaya Y, Abad MRA, Fujiyoshi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases. Dig Endosc. 2021;33(3):347-354. http://doi.org/10.1111/den.13727 DOI: https://doi.org/10.1111/den.13727
Inoue H, Tanabe M, de Santiago ER, Abad MRA, Shimamura Y, Fujiyoshi Y, et al. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. Endosc Int Open. 2020;8(2):E133-E138. http://doi.org/10.1055/a-1031-9436 DOI: https://doi.org/10.1055/a-1031-9436